Combined HER3-EGFR score in triple-negative breast cancer provides prognostic and predictive significance superior to individual biomarkers.

导出 LinkOut

翻译打印收藏纠错

第一作者： Angela,Ogden

第一单位： Department of Biology, Georgia State University, Atlanta, GA, USA.

作者： Angela,Ogden ^[1] ; Shristi,Bhattarai ^[1] ; Bikram,Sahoo ^[1] ; Nigel P,Mongan ^[2] ; Mansour,Alsaleem ^[3] ; Andrew R,Green ^[4] ; Mohammed,Aleskandarany ^[4] ; Ian O,Ellis ^[4] ; Sonal,Pattni ^[4] ; Xiaoxian Bill,Li ^[5] ; Carlos S,Moreno ^[5] ; Uma,Krishnamurti ^[5] ; Emiel A,Janssen ^[5] ; Kristin,Jonsdottir ^[6] ; Emad,Rakha ^[7] ; Padmashree,Rida ^[6] ; Ritu,Aneja ^[2]

作者单位： Department of Biology, Georgia State University, Atlanta, GA, USA. ^[1] Faculty of Medicine and Health Science, School of Veterinary Medicine and Science, University of Nottingham, Nottingham, LE12 5RD, UK. ^[2] Department of Pharmacology, Weill Cornell Medicine, 1300, York Ave., NY, USA. ^[3] Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham Biodiscovery Institute, University Park, Nottingham, NG7 2RD, UK. ^[4] Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA. ^[5] Department of Pathology, Stavanger University Hospital, Stavanger, Norway. ^[6] Department of Chemistry, Bioscience and Environmental Engineering, University of Stavanger, 4036, Stavanger, Norway. ^[7] Novazoi Theranostics, Inc., Rolling Hills Estates, CA, USA. cgp_rida@yahoo.com. ^[8] Department of Biology, Georgia State University, Atlanta, GA, USA. raneja@gsu.edu. ^[9]